From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among...

The Biotech Training Facility at Leiden Bio Science Park welcomed the Merck on Tour mobile lab, a travelling showcase of the latest life science...

MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular...

Azafaros has raised €132 million in an oversubscribed Series B financing round. The funding will support the advancement of its lead clinical-stage...

Two Leiden University research teams have been awarded grants through the HTSM programme, supporting advanced technology development with strong...

Researchers at Leiden University Medical Center (LUMC) have developed PERISCOPE, an AI-driven tool designed to predict the risk of infections in...

NecstGen has partnered with Paris-based biotech Astraveus to evaluate the Lakhesys™ Benchtop Cell Factory™, a microfluidic-based platform aiming to...

Leiden Bio Science Park welcomed a delegation from Trinity College Cambridge to explore shared innovation goals and strengthen ties between two leading science ecosystems. The visit featured knowledge exchange, campus tours, and conversations on how to grow talent, research, and global biotech impact.

What if you could design something that acts like an antibody, but cheaper, more stable, and made entirely with chemistry? Two LACDR researchers,...